Autobio Diagnostics Co., Ltd.
SHH: 603658.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Zeng Li Yang
- Employees
- 5,773
- Headquarters
- Zhengzhou, China
- IPO year
- 2016
- Market cap
- CN¥19.5B
- Website
- https://www.autobio.com.cn
Loading 603658…
Loading profile data…Frequently asked questions about 603658
What does Autobio Diagnostics Co., Ltd. (603658.SS) do?
Autobio Diagnostics Co., Ltd. engages in the research and development, production, and distribution of clinical diagnostic products. It develops immunoassay, biochemistry, microbiology, and IVD reagents; and instruments, such as automation and semi-automation systems, as well as medical laboratory solutions. The company's immunoassay products Au...
Where does 603658.SS trade?
Autobio Diagnostics Co., Ltd. (603658.SS) trades on the Shanghai Stock Exchange.
What sector is 603658.SS in?
Autobio Diagnostics Co., Ltd. (603658.SS) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Autobio Diagnostics Co., Ltd.?
Zeng Li Yang is the chief executive officer of Autobio Diagnostics Co., Ltd. (603658.SS).
Where is Autobio Diagnostics Co., Ltd. headquartered?
Autobio Diagnostics Co., Ltd. is headquartered in China.
Does 603658.SS pay a dividend?
Yes — Autobio Diagnostics Co., Ltd. (603658.SS) paid a trailing twelve-month dividend of CNY 1.26 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603658.SS go public?
Autobio Diagnostics Co., Ltd. (603658.SS) completed its initial public offering in 2016.